Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 141, pseudogene" (RNU6-141P) is a **pseudogene** derived from the U6 small nuclear RNA (snRNA) gene family. The canonical U6 snRNA plays a fundamental role in the spliceosome—the cellular machinery responsible for intron removal from pre-mRNA during RNA splicing[1]. Pseudogenes like RNU6-141P are not functional genes; they are genomic DNA sequences similar to their parent snRNA genes but typically lack promoter elements or other critical features necessary for normal transcription or biological activity[2][4]. U6 snRNA pseudogenes are processed genomic sequences often generated through retrotransposition events and can be used as genomic markers for studying the dynamics of retrotransposition but do not encode active RNA or protein products and are not considered therapeutic drug targets[2]. **Notes/Special clarifications:** - *is_target* is **false** because, as a pseudogene, RNU6-141P does not produce an active molecule and has no known function as a therapeutic target (e.g., not a receptor, enzyme, transporter, or signaling molecule). - *is_incorrect* is **true** because it is commonly a data annotation error to treat a pseudogene (especially a non-functional RNA pseudogene) as a molecular drug target. - No drugs, disease associations, or biomarker utility are known or expected for this entity, and it is not used in therapeutic development or clinical monitoring[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on U6 small nuclear RNA 141, pseudogene (RNU6-141P).